Use of Aromatase Inhibitors in Children and Adolescents with Disorders of Growth and Adolescent Development (Pediatrics 2008)

A review of published data regarding the use of aromatase inhibitors in pediatrics.

Changes in Recombinant Human Growth Hormone Prescribing Information (PES D & T Committee 2008)

Members of the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society describe the changes in the prescribing information for the different forms of
rhGH.

Endocrine Outcomes for Children with Embryonal Brain Tumors After Risk-Adapted Craniospinal and Conformal Primary-Site Irradiation and High-Dose Chemotherapy with Stem-Cell Rescue on the SJMB-96 Trial (J Clin Oncol. 2008)

Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents (Circul 2007)

A Scientific Statement from the American Heart Association on Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents.

Increasing Minority Participation in Clinical Research

Update of Newborn Screening and Therapy for Congenital Hypothyroidism (Pediatrics 2006)

Consensus Statement on Management of Intersex Disorders

The birth of an intersex child prompts a long-term management strategy that involves myriad professionals working with the family. There has been progress in diagnosis, surgical…

Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes. PES D&T Committee Position statement. (Pediatrics 2006)

This review summarizes efficacy and safety of continuous subcutaneous insulin infusion in children ≤6 years of age, present potential pros and cons of using insulin pumps…

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Prospective study conducted by the Diabetes Prevention Program Research Group, looking at reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Childhood Obesity (JCEM 2005)

A consensus statement on the widespread public health crisis in childhood obesity.

Load More